-
2024-11-20
Chinese Monoclonal Anti-IL-1β Breakthrough: Acute Gout Arthritis Treatment Impresses at ACR 2024Learn More
-
2024-11-11
World ADC San Diego 2024: GenSci showcases two innovative pipeline programsLearn More
-
2024-11-07
Welcome to Visit Us at MEDICA 2024Learn More
-
2024-10-25
GenSci' s Inaugural R&D Day 2024: Innovation in Gene, Science in Actionsuccessfully concluded on October 17, 2024
Learn More
-
2024-07-26
Zhejiang University – GenSci Joint Research Center of Children’s Health establishedLearn More
-
2024-07-09
R&D Innovation Accelerator: Shanghai Children's Hospital and GenSci Ink Strategic Cooperation AgreementTwo Sides will Collaboratively Set Up a R&D Center
Learn More
-
2024-07-03
GenSci Invites you to join us in CPHI South East Asia 2024Join us at Booth H23 from July 10 to 12, 2024 to explore GenSci's flagship products.
Learn More
-
2024-06-28
China's First Aqueous Solution Progesterone Injection, Jin Sai Xin® ApprovedA further step towards GenSci's vision of becoming a global leader in Pediatric and Women's Health
Learn More
-
2024-06-05
Visit GenSci at CPhI China 2024At Booth W4E59, See you there!
Learn More
-
2024-12-12
GenSci Invites You to Meet Us at Arab Health 2025Learn More
-
2024-09-24
Meet GenSci at CPhI Milan 2024Learn More
-
2024-09-23
GenSci showcases the innovative pipelines at ChinaBio®Learn More
-
2024-09-03
GenSci Invites You to Meet Us at Pharmedi Vietnam 2024Learn More
-
2024-08-29
GenSci098 Injection Obtains Implied License For Clinical Trials of FDALearn More
-
2024-08-21
Jintrolong® New Dosage Form of Long-acting Somatropin Injection ApprovedLearn More